Tag Archives: informed consent
A surprisingly uncritical piece on Big Pharma’s unfettered hold on China’s health care
Not that medications do not have a place in the treatment armamentarium, but what about proper, expertise-based diagnosis first? What about the undisclosed conflicts of interest rampant in Chinese hospitals? Informed consent? Both an outsized version of the situation in … Continue reading →
Metabolic Fate of Pharmaceuticals: A Focus on Slow Metabolizers
Very interesting and timely PowerPoint focusing on (now increasingly preventable) adverse outcomes, not on metabolism-related lack of efficacy. >>It has been shown that variability in drug metabolism can have a substantial effect on clinical outcomes in patients. The impact of … Continue reading →
The Pros and Cons of Concierge Medical Care | NYCityWoman.com
The Pros and Cons of Concierge Medical Care | NYCityWoman.com A thoughtful and balanced, and (yes) enthusiastic discussion of what it means to have a personal physician in U.S.A. anno 2013. Written by Sally Wendkos Olds, happy patient of Margaret … Continue reading →
Simvastatin impairs exercise training adaptations.
Simvastatin impairs exercise training adaptations. Mikus CR, et al. Show all J Am Coll Cardiol. 2013 Aug 20;62(8):709-14. doi: 10.1016/j.jacc.2013.02.074. Epub 2013 Apr 10. Affiliation Division of Cardiology, Duke University Medical Center, Durham, North Carolina. Abstract OBJECTIVES: This study sought … Continue reading →
Long-term use of statins may be associated with increased risks of both ductal and lobular breast cancer among women 55-74 years of age
Search Home PDF Current Issue Past Issues OnlineFirst Long-term statin use and risk of ductal and lobular breast cancer among women 55-74 years of age Authors Abstract Background: Mechanistic studies largely support the chemopreventive potential of statins. However, results of … Continue reading →